Literature DB >> 7733127

The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

A D Krahn1, J Manfreda, R B Tate, F A Mathewson, T E Cuddy.   

Abstract

PURPOSE: Atrial fibrillation is a common arrhythmia associated with increased cardiovascular morbidity and mortality. This study was undertaken to identify the natural history of this condition, including risk factors for its development, and outcome. PATIENTS AND METHODS: The incidence of atrial fibrillation among 3,983 male air crew recruits observed continuously for 44 years was calculated based on person-years of observation. Age and 23 variables were examined to identify risk factors for atrial fibrillation. Controlling for age and 9 prognostic variables, the effect of atrial fibrillation on 8 outcomes was examined. Analysis of risk factors for atrial fibrillation and outcome after atrial fibrillation was based on a Cox proportional hazard model using time-dependent covariates.
RESULTS: Of the 3,983 study members, 299 (7.5%) developed atrial fibrillation during 154,131 person-years of observation. The incidence rose with age from less than 0.5 per 1,000 person-years before age 50 to 9.7 per 1,000 person-years after age 70. Risk for atrial fibrillation was increased with myocardial infarction (relative risk [RR] 3.62), angina (RR 2.84), and ST-T wave abnormalities in the absence of ischemic heart disease (RR 2.21). The RR for atrial fibrillation was strongest at the onset of ischemic heart disease and diminished over time. The rate of atrial fibrillation was 1.42 times increased in men with a history of hypertension. Congestive heart failure, valvular heart disease, and cardiomyopathy were important but uncommon risk factors. Atrial fibrillation independently increased the risk for stroke (RR 2.07) and congestive heart failure (RR 2.98). Total mortality rate was increased 1.31 times; cardiovascular mortality including and excluding fatal stroke were also increased (RR 1.41 and 1.37, respectively).
CONCLUSIONS: The incidence of atrial fibrillation in men increases with advancing age. Clinical cardiac abnormalities, particularly recent ischemic heart disease and hypertension, are strongly associated with increased risk for atrial fibrillation. Atrial fibrillation increases morbidity and mortality, but the magnitude of the increase may be less than previously reported.

Entities:  

Mesh:

Year:  1995        PMID: 7733127     DOI: 10.1016/S0002-9343(99)80348-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  331 in total

Review 1.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

Review 2.  Chronic and paroxysmal atrial fibrillation: course, prognosis, and stroke risk.

Authors:  T E Cuddy
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 3.  Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Authors:  I Savelieva; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

4.  Validation of an atrial fibrillation risk algorithm in whites and African Americans.

Authors:  Renate B Schnabel; Thor Aspelund; Guo Li; Lisa M Sullivan; Astrid Suchy-Dicey; Tamara B Harris; Michael J Pencina; Ralph B D'Agostino; Daniel Levy; William B Kannel; Thomas J Wang; Richard A Kronmal; Philip A Wolf; Gregory L Burke; Lenore J Launer; Ramachandran S Vasan; Bruce M Psaty; Emelia J Benjamin; Vilmundur Gudnason; Susan R Heckbert
Journal:  Arch Intern Med       Date:  2010-11-22

5.  Potential association between frequent nonsynonymous variant of NPPA and cardioembolic stroke.

Authors:  Jeong-Hyun Kim; Bo-Hyung Jang; Ho Yeon Go; Sunju Park; Yong-Cheol Shin; Sung-Hoon Kim; Seong-Gyu Ko
Journal:  DNA Cell Biol       Date:  2012-03-08       Impact factor: 3.311

Review 6.  Promise of factor Xa inhibition in atrial fibrillation.

Authors:  Sana M Al-Khatib; John H Alexander; Renato D Lopes; Kenneth W Mahaffey; Manesh R Patel; Christopher B Granger
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

7.  Assessment of atrial conduction time by tissue Doppler echocardiography and P-wave dispersion in smokers.

Authors:  Erdal Akturk; Jülide Yağmur; Nusret Açıkgöz; Necip Ermiş; Mehmet Cansel; Yasin Karakuş; Hakan Taşolar; Ferhat Eyupkoca; Hasan Pekdemir
Journal:  J Interv Card Electrophysiol       Date:  2012-03-06       Impact factor: 1.900

8.  Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study.

Authors:  Lars Frost; Emelia J Benjamin; Morten Fenger-Grøn; Asger Pedersen; Anne Tjønneland; Kim Overvad
Journal:  Obesity (Silver Spring)       Date:  2014-02-18       Impact factor: 5.002

9.  Prevalence and predictors of atrial fibrillation among patients undergoing bariatric surgery.

Authors:  M Benjamin Shoemaker; Sanaz Gidfar; Daniel C Pipilas; Robyn A Tamboli; Eleonora Savio Galimberti; D Brandon Williams; Ronald H Clements; Dawood Darbar
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

10.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.

Authors:  S Stewart; C L Hart; D J Hole; J J McMurray
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.